Physician profile
Vivek Sindhi
NPI 1841679768
$33,342.88
in general payments reported to CMS, 2019-2025
29 companies · $4,750 in 2025
The $4,750 reported for 2025 was more than what 97% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $4,327 · 2021: $732 · 2022: $690 · 2023: $3,242 · 2024: $19K · 2025: $4,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,925 · Food and Beverage: $6,197 · Travel and Lodging: $2,723 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,925.00 |
| Food and Beverage | $6,196.76 |
| Travel and Lodging | $2,723.34 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $10,402.58 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic, INC. | $8,737.13 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Globus Medical, INC. | $4,177.11 | 2025 | Senza |
| Medtronic USA, INC. | $3,510.05 | 2019-2020 | |
| Stryker Corporation | $2,644.15 | 2021-2025 | Mild Device Kit, Optablate |
| Nevro Corp. | $1,374.34 | 2021-2024 | Senza |
| Relievant Medsystems, INC. | $994.92 | 2019-2023 | Intracept |
| Vertos Medical, INC. | $264.57 | 2021-2024 | Mild Device Kit |
| Boston Scientific Corporation | $180.39 | 2022-2025 | Wavewriter Alpha Prime 16, Varithena Administration Pack, Intracept |
| Painteq LLC | $171.82 | 2024 | Painteq |
| Abbott Laboratories | $150.90 | 2020-2024 | Proclaim, Eterna |
| Grt US Holding, INC. | $126.98 | 2021 | |
| Bioness INC | $119.16 | 2021 | |
| Averitas Pharma INC. | $99.07 | 2023 | Qutenza |
| Spr Therapeutics, INC | $52.95 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $45.52 | 2023-2024 | Prospera, Biotronik |
| Trevena, INC. | $40.42 | 2022 | |
| Amneal Pharmaceuticals LLC | $32.24 | 2023 | Lyvispah |
| Tonix Medicines, INC. | $27.51 | 2025 | Tonmya |
| Amgen INC. | $26.88 | 2024 | Prolia, Evenity |
| Mml US, INC. | $25.58 | 2023 | Reactiv8 |
| Deciphera Pharmaceuticals INC. | $22.62 | 2021 | |
| Si-Bone, INC. | $20.35 | 2023 | |
| Merz North America, INC. | $19.01 | 2019 | |
| Pfizer INC. | $18.82 | 2023 | |
| Merz Pharmaceuticals, LLC | $16.23 | 2023 | Xeomin |
| Vertex Pharmaceuticals Incorporated | $15.66 | 2025 | |
| Fidia Pharma USA INC. | $13.37 | 2024 | Hymovis, Triluron, Hyalgan |
| Curonix LLC | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Sindhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.